Ceruloplasmin and the Extent of Heart Failure in Ischemic and Nonischemic Cardiomyopathy Patients

Table 4

Relationship between extent of heart failure and clinical and laboratory parameters in patients with nonischemic cardiomyopathy.

Variables	OR	𝜒^2	𝑃 value	95% confidence interval
				Lower bound	Upper bound
Age	1.072	3.997	0.046*	1.001	1.148
Gender	0.293	1.426	0.232	0.039	2.198
Smoking	1.499	0.172	0.678	0.222	10.136
Alcohol	0.993	0.000	0.994	0.125	7.874
Hypertension	2.330	1.214	0.270	0.518	10.492
Diabetes mellitus	1.047	0.002	0.967	0.121	9.026
Creatinine	0.157	1.029	0.310	0.004	5.609
ALT	1.019	0.339	0.560	0.957	1.084
AST	0.972	0.700	0.403	0.910	1.039
LDL-C	1.026	0.481	0.488	0.954	1.103
Total cholesterol	0.981	0.621	0.431	0.935	1.029
Triglycerides	0.998	0.076	0.782	0.981	1.014
Uric Acid	1.141	0.530	0.467	0.800	1.629
CK	1.006	1.962	0.161	0.998	1.013
CKMB	1.069	0.937	0.333	0.934	1.223
Troponin I	1.304	1.011	0.315	0.778	2.185
CRP	1.012	0.255	0.614	0.966	1.061
Homocysteic acid	1.009	0.057	0.811	0.937	1.087
LVEF	0.981	1.479	0.224	0.952	1.012
LVIDd	0.616	0.502	0.479	0.161	2,354
LA	0.839	0.097	0.755	0.280	2.519
Ceruloplasmin	1.010	4.489	0.034*	1.001	1.019

ALT: alanine aminotransferase; AST: aspartate aminotransferase; CK: creatinine kinase; CK-MB: creatinine kinase-MB; CRP: C-reactive protein; LA: left atrium; LDL-C: low-density lipoprotein cholesterol; LVEF: left-ventricular ejection fraction; LVIDd: left-ventricular internal diameter at end diastole. *𝑃<0.05.